Multidrug-resistant Acinetobacter baumannii osteomyelitis from Iraq

Emerging Infectious Diseases

Volumn 14, Issue 3, 2008, Pages 512-514

  Schafer, Jason J ^a,b   Mangino, Julie E ^a  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b St Margaret Memorial Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; IMIPENEM; TIGECYCLINE; TOBRAMYCIN; VANCOMYCIN;

ACINETOBACTER BAUMANNII; ADULT; ANTIBIOTIC SENSITIVITY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMUR FRACTURE; HUMAN; IRAQ; LABORATORY TEST; LETTER; MALE; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; OSTEOMYELITIS; PATIENT TRANSPORT; RADIODIAGNOSIS; STAPHYLOCOCCUS;

EID: 41349104285     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1403.070128     Document Type: Letter

References (10)

1. Centers for Disease Control and Prevention. Acinetobacter baumannii infections among patients at military medical facilities treating injured U.S. service members, 2002-2004. MMWR Morb Mortal Wkly Rep. 2004;53:1063-6.
2. Hujer KM, Hujer AM, Hulten EA, Bajaksouzian S, Adams JM, Donskey CJ, et al. Multi-drug resistant Acinetobacter spp. isolates from military and civilian patients treated at the Walter Reed Army Medical Center: analysis of antibiotic resistance genes. Antimicrob Agents Chemother. 2006;50:4114-23.
3. Davis KA, Moran KA, McAllister CK, Gray PJ. Multidrug-resistant Acinetobacter extremity infections in soldiers. Emerg Infect Dis. 2005;11:1218-24.
4. Waites KB, Duffy LB, Dowzicky MJ. Antimicrobial susceptibility among pathogens collected from hospitalized patients in the United States and in vitro activity of tigecycline, a new glycylcycline antimicrobial. Antimicrob Agents Chemother. 2006;50:3479-84.
5. Navon-Venezia S, Leavitt A, Carmeli Y. High tigecycline resistance in multidrug-resistant Acinetobacter baumannii. J Antimicrob Chemother. 2007;59:772-4.
6. Yin LY, Lazzarini L, Li F, Stevens CM, Calhoun JH. Comparative evaluation of tigecycline and vancomycin, with and without rifampicin, in the treatment of methicillin-resistant Staphylococcus aureus experimental osteomyelitis in a rabbit model. J Antimicrob Chemother. 2005;55:995-1002.
7. Tombs NL. Tissue distribution of GAR-936, a broad spectrum antibiotic in male rats. In: Program and abstracts of the Thirty-ninth Interscience Conference on Antimicrobial Agents and Chemotherapy. 1999 Sep 26-29 (San Francisco). Washington: American Society for Microbiology; 1999. p. 413.
8. Rodvold KA, Gotfried MH, Cwik M, Korth-Bradley JM, Dukart G, Ellis-Grosse EJ. Serum, tissue and body fluid concentrations of tigecycline after a single 100 mg dose. J Antimicrob Chemother. 2006;58:1221-9.
9. Ji AJ, Saunders P, Amorushi P, Wadgaonkar ND, Leal M, Fluhler EN. A sensitive human bone assay for quantification of tigecycline using LC/MS/MS. In: Program and abstracts of the Forty-sixth Interscience Conference on Antimicrobial Agents and Chemotherapy. 2006 Sept 17-20 (San Francisco). Washington: American Society for Microbiology; 2006. p. 1952.
10. Wininger DA, Fass RJ. Antibiotic cement and beads for orthopedic infections. Antimicrob Agents Chemother. 1996;40:2675-9.